vs
Inventiva S.A.（IVA）与Algorhythm Holdings, Inc.（RIME）财务数据对比。点击上方公司名可切换其他公司
Algorhythm Holdings, Inc.净利率更高（169.1% vs -961352.9%，领先961522.0%）
Inventiva S.A.是一家处于临床阶段的生物制药企业，专注于开发针对纤维化、罕见病及肿瘤领域的口服创新疗法，在欧洲、北美设有核心业务分支，致力于为全球存在未被满足临床需求的患者提供治疗方案。
Algorhythm Holdings是一家专注于医疗领域人工智能临床决策支持解决方案的科技公司，主要服务北美地区医疗机构，旗下产品可提升诊疗质量、简化临床工作流程、降低运营成本。
IVA vs RIME — 直观对比
营收规模更大
IVA
是对方的-0.0倍
$-2.1M
净利率更高
RIME
高出961522.0%
-961352.9%
损益表 — Q2 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.1K | $-2.1M |
| 净利润 | $-49.0M | $-3.5M |
| 毛利率 | — | 117.3% |
| 营业利润率 | — | 135.4% |
| 净利率 | -961352.9% | 169.1% |
| 营收同比 | — | 56.1% |
| 净利润同比 | — | 78.2% |
| 每股收益（稀释后） | — | $-0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVARIME
| Q4 25 | — | $-2.1M | ||
| Q2 25 | — | $2.7M | ||
| Q4 24 | — | $-4.7M | ||
| Q2 24 | $5.1K | $2.4M | ||
| Q1 24 | — | $2.4M | ||
| Q3 23 | — | $15.9M | ||
| Q2 23 | — | $2.6M | ||
| Q4 22 | — | $7.1M |
净利润IVARIME
| Q4 25 | — | $-3.5M | ||
| Q2 25 | — | $-809.0K | ||
| Q4 24 | — | $-16.0M | ||
| Q2 24 | $-49.0M | $-6.1M | ||
| Q1 24 | — | $-2.4M | ||
| Q3 23 | — | $97.5K | ||
| Q2 23 | — | $-2.5M | ||
| Q4 22 | — | $-1.9M |
毛利率IVARIME
| Q4 25 | — | 117.3% | ||
| Q2 25 | — | 35.1% | ||
| Q4 24 | — | — | ||
| Q2 24 | — | 13.3% | ||
| Q1 24 | — | 20.7% | ||
| Q3 23 | — | 23.4% | ||
| Q2 23 | — | 20.2% | ||
| Q4 22 | — | 18.1% |
营业利润率IVARIME
| Q4 25 | — | 135.4% | ||
| Q2 25 | — | -28.8% | ||
| Q4 24 | — | — | ||
| Q2 24 | — | -252.2% | ||
| Q1 24 | — | -94.3% | ||
| Q3 23 | — | 0.7% | ||
| Q2 23 | — | -92.6% | ||
| Q4 22 | — | -32.1% |
净利率IVARIME
| Q4 25 | — | 169.1% | ||
| Q2 25 | — | -29.8% | ||
| Q4 24 | — | 340.0% | ||
| Q2 24 | -961352.9% | -250.8% | ||
| Q1 24 | — | -97.6% | ||
| Q3 23 | — | 0.6% | ||
| Q2 23 | — | -93.7% | ||
| Q4 22 | — | -27.2% |
每股收益（稀释后）IVARIME
| Q4 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.24 | ||
| Q4 24 | — | $-89.56 | ||
| Q2 24 | — | $-190.68 | ||
| Q1 24 | — | $-73.76 | ||
| Q3 23 | — | $0.03 | ||
| Q2 23 | — | $-0.64 | ||
| Q4 22 | — | $-0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-85.4M | $-1.9M |
| 总资产 | $42.6M | $12.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IVARIME
| Q4 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | $11.0M | $1.2M | ||
| Q1 24 | — | $4.1M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $1.9M | ||
| Q4 22 | — | $2.8M |
股东权益IVARIME
| Q4 25 | — | $-1.9M | ||
| Q2 25 | — | $2.8M | ||
| Q4 24 | — | $-10.5M | ||
| Q2 24 | $-85.4M | $-872.0K | ||
| Q1 24 | — | $5.2M | ||
| Q3 23 | — | $9.7M | ||
| Q2 23 | — | $9.5M | ||
| Q4 22 | — | $13.2M |
总资产IVARIME
| Q4 25 | — | $12.7M | ||
| Q2 25 | — | $12.7M | ||
| Q4 24 | — | $18.3M | ||
| Q2 24 | $42.6M | $12.4M | ||
| Q1 24 | — | $19.9M | ||
| Q3 23 | — | $32.6M | ||
| Q2 23 | — | $15.0M | ||
| Q4 22 | — | $24.2M |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
